background
rift
valley
fever
rvf
mosquitoborn
viral
zoonosi
detect
rvf
viru
rvfv
infect
indirect
immunoglobulin
g
igg
immunoglobulin
igm
enzym
link
immunosorb
assay
elisa
util
recombin
rvfv
nucleocapsid
rvfvn
protein
assay
antigen
reportedli
use
howev
still
need
develop
sensit
specif
method
detect
method
rvfvn
protein
express
escherichia
coli
e
coli
purifi
histidinetag
base
affin
chromatographi
recombin
rvfvn
rrvfvn
protein
use
antigen
develop
igg
sandwich
elisa
igm
captur
elisa
human
sera
nineti
six
serum
sampl
collect
healthi
volunt
rvf
surveil
programm
kenya
serum
sampl
collect
rvfsuspect
patient
rvf
outbreak
kenya
use
respect
evalu
newli
establish
rrvfvn
proteinbas
igg
sandwich
elisa
igm
captur
elisa
system
comparison
inactiv
virusbas
elisa
system
result
rrvfvn
proteinbasedigg
sandwich
elisa
igm
captur
elisa
human
sera
establish
new
elisa
system
concord
inactiv
virusbas
elisa
system
sensit
specif
conclus
recombin
rvfvn
safe
afford
antigen
rvf
diagnosi
rrvfvnbase
elisa
system
safe
reliabl
tool
diagnosi
rvfv
infect
human
especi
use
largescal
epidemiolog
investig
applic
develop
countri
rift
valley
fever
rvf
mosquitoborn
viral
zoonosi
period
caus
diseas
outbreak
human
livestock
infect
rvf
viru
rvfv
caus
abort
resorpt
fetu
pregnant
domest
rumin
newborn
mortal
approach
transmiss
rvfv
human
either
contact
bodili
fluid
infect
anim
mosquito
bite
may
result
mild
moder
influenzalik
symptom
sever
retin
enceph
hemorrhag
fever
rvfv
first
describ
kenya
major
outbreak
rvf
report
egypt
kenya
saudi
arabia
yemen
south
africa
recent
outbreak
rvf
kenya
novemb
march
sever
hundr
human
case
confirm
provinc
devastatingli
high
casefat
rate
hospit
patient
infect
mildli
ill
asymptomat
peopl
within
highli
affect
area
serosurvey
suggest
attack
rate
resid
heavili
affect
area
livestock
death
abort
also
note
outbreak
rvfv
belong
order
bunyaviral
famili
phenuivirida
genu
phleboviru
member
famili
carri
triseg
singl
strand
rna
genom
medium
l
larg
segment
neg
orient
wherea
small
segment
ambisens
polar
l
segment
encod
rnadepend
rnapolymeras
segment
encod
two
glycoprotein
gn
gc
also
nonstructur
protein
nsm
small
segment
encod
nucleocapsid
n
protein
nonstructur
protein
nss
use
ambisens
code
strategi
n
protein
highli
conserv
one
immunodomin
viral
protein
among
member
phenuivirida
famili
elisa
system
base
inactiv
antigen
deriv
tissu
cultur
mous
brain
valid
rvf
serodiagnosi
human
anim
high
product
cost
antigen
requir
high
biocontain
facil
limit
applic
rrvfvnbase
elisa
system
report
diagnosi
rvfv
infect
human
anim
rrvfvnbase
elisa
system
human
use
indirect
igg
indirect
igm
method
report
rrvfvnbase
iggsandwich
igm
captur
elisa
human
serum
human
serodiagnosi
applic
rrvfvn
protein
limit
whole
virusbas
elisa
system
still
recommend
rvf
diagnosi
evalu
possibl
use
rrvfvn
protein
safe
afford
antigen
serodiagnosi
rvfv
infect
clone
full
length
rvfv
n
gene
express
n
protein
ecoli
purifi
n
protein
evalu
rrvfvnbase
elisa
system
comparison
exist
inactiv
rvfvbase
elisa
system
nineti
six
serum
sampl
collect
healthi
volunt
rvf
surveil
studi
kenya
serum
sampl
collect
suspectedrvf
patient
rvf
outbreak
kenya
use
experi
detect
igg
igm
rvfv
respect
wild
type
rvfv
isol
isol
mosquito
collect
rvf
outbreak
kenya
use
construct
rvfv
recombin
plasmid
wild
type
viru
cultur
kenya
medic
research
institut
passag
rna
rvfv
infect
cultur
fluid
vero
cell
extract
use
qiaamp
viral
mini
kit
qiagen
hilden
germani
accord
manufactur
instruct
rvfv
n
gene
amplifi
rtpcr
use
sens
primer
revers
primer
sens
revers
primer
contain
bam
hi
sal
restrict
site
underlin
nucleotid
respect
pcr
amplifi
dna
fragment
digest
bam
hi
sal
purifi
qiaex
ii
gel
extract
kit
qiagen
hilden
germani
subsequ
clone
correspond
restrict
site
vector
qiagen
hilden
germani
insert
recombin
plasmid
confirm
frame
dna
sequenc
express
construct
encompass
code
region
amino
acid
aa
full
length
rvfvn
protein
vector
deriv
histag
histidin
hexam
nterminu
obtain
result
recombin
protein
design
recombin
rvfvn
protein
rrvfvn
protein
express
insert
recombin
plasmid
contain
rvfvn
sequenc
e
coli
strain
blue
express
purif
done
describ
previous
briefli
e
coli
strain
blue
contain
rrvfvn
recombin
plasmid
cultur
litr
luriabertani
lb
medium
contain
ampicillin
induc
hr
mm
isopropyl
iptg
optic
densiti
od
nm
reach
harvest
centrifug
min
e
coli
pellet
resuspend
mm
pb
ph
mm
nacl
frozen
freez
thaw
three
time
cell
suspens
sonic
min
interv
puls
centrifug
g
min
supernat
appli
imac
resin
column
clontech
usa
rrvfvn
protein
purifi
accord
manufactur
instruct
protein
concentr
determin
bradford
method
use
biorad
protein
assay
reagent
kit
biorad
usa
puriti
protein
analyz
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
western
blot
analysi
perform
describ
previous
briefli
recombin
protein
separ
sdspage
transfer
onto
pvdf
membran
immobilon
millipor
usa
block
blockac
yokijirushi
sapporo
japan
overnight
membran
subject
reaction
rabbit
rvfv
hyperimmun
sera
mous
antihistidin
dilut
hr
follow
incub
horseradish
peroxidas
conjugatedgoat
antirabbit
igg
rabbit
antimous
igg
dilut
hr
final
reaction
visual
dimethyl
amino
benzidin
dab
stain
prepar
rabbit
hyperimmun
sera
rvfv
two
litr
infect
cultur
fluid
icf
harvest
cultur
vero
cell
day
inocul
rvfv
smithburn
strain
icf
purifi
sucrosegradi
ultracentrifug
x
g
hr
purifi
viru
mgml
inactiv
final
concentr
formalin
day
two
new
zealand
white
rabbit
immun
formalininactiv
viru
mix
equal
volum
freund
complet
adjuv
mgshotrabbit
week
boost
thrice
formailininactiv
viru
mix
equal
volum
freund
incomplet
adjuv
interv
week
serum
collect
rabbit
antiviru
igg
purifi
use
mab
trap
kit
ge
healthcar
accord
manufactur
instruct
rsftsvn
protein
express
insert
recombin
plasmid
contain
n
gene
sequenc
sever
thrombocytopenia
syndrom
viru
newli
emerg
phleboviru
east
asia
e
coli
strain
blue
purifi
follow
procedur
describ
previous
protein
use
neg
antigen
newli
develop
elisa
system
evalu
possibl
appli
rrvfvn
protein
diagnosi
rvfv
infect
develop
igg
sandwich
igm
captur
elisa
system
human
sera
use
rrvfvn
protein
antigen
result
compar
inactiv
virusbas
elisa
system
routin
use
rvf
refer
diagnost
laboratori
elisa
procedur
plate
use
nunc
immunopl
thermo
scientif
denmark
reagent
volum
wash
buffer
pb
volvol
tween
pbst
plate
wash
thrice
pbst
reagent
step
coat
buffer
pb
ph
coat
plate
left
overnight
subsequ
serum
sampl
reagent
dilut
done
pbst
nonfat
milk
difco
detroit
usa
incub
except
substrat
done
hr
plate
ad
h
abt
substrat
kirkegaard
perri
gaithersburg
md
incub
min
read
spectrophotometr
plate
control
serum
sampl
name
posit
control
weak
posit
control
neg
control
ad
optic
densiti
od
valu
nm
record
adjust
od
calcul
subtract
od
neg
antigen
react
well
od
posit
antigen
react
well
od
cutoff
valu
calcul
mean
adjust
od
neg
control
sera
plu
three
time
standard
deviat
gener
would
give
od
sampl
dilut
serum
sampl
consid
posit
adjust
od
valu
greater
equal
assay
cutoff
ever
valu
higher
igg
sandwich
elisa
system
use
inactiv
rvfv
routin
use
rvf
diagnosi
refer
laboratori
kenya
medic
research
institut
viru
strain
use
inactiv
virusbas
assay
system
strain
genbank
viru
propag
vero
cell
infect
cultur
fluid
supernat
cell
provid
rvfv
antigen
use
assay
supernat
inactiv
use
betapropiolacton
cobalt
irradi
use
million
rad
test
safeti
use
establish
protocol
briefli
sampl
test
well
subject
follow
reaction
step
coat
antirvfv
hyperimmun
mous
ascet
fluid
hmaf
dilut
addit
dilut
inactiv
rvfv
cultur
fluid
posit
antigen
two
well
two
well
dilut
mock
cultur
fluid
neg
antigen
follow
addit
test
serum
sampl
dilut
well
detect
bound
igg
dilut
peroxidaseconjug
mous
antihuman
igg
fc
specif
accur
chemic
scientif
corp
westburi
ny
abt
substrat
ad
produc
color
reaction
od
detect
initi
experi
procedur
appli
serum
sampl
result
obtain
compar
result
inactiv
viru
antigen
inaciv
viru
base
sandwich
elisa
system
replac
rrvfn
ngwell
produc
comparison
done
determin
reactiv
rrvfn
inactiv
virusbas
elisa
system
use
refer
laboratori
kenya
procedur
develop
igg
sandwich
elisa
util
rrvfvn
follow
step
inactiv
virusbas
elisa
procedur
modif
briefli
serum
sampl
well
subject
follow
reaction
step
coat
dilut
purifi
rabbit
rvfv
hyperimmun
serum
igg
prepar
mention
addit
ng
rrvfvn
protein
posit
antigen
two
well
ng
rsftsvn
protein
neg
antigen
two
well
follow
addit
dilut
human
serum
sampl
four
well
addit
dilut
horseradishperoxidaseconjug
goat
antihuman
igg
american
qualex
califonia
usa
lastli
color
develop
done
addit
abt
substrat
optim
concentr
captur
antibodi
purifi
rabbit
rvfv
hyperimmun
serum
igg
use
coat
plate
rrvfvn
protein
determin
checkerboard
titrat
two
posit
two
neg
refer
serum
sampl
igm
captur
elisa
system
use
inactiv
rvfv
routin
use
diagnosi
rvf
diagnosi
refer
laboratori
kenya
medic
research
institut
briefli
sampl
test
well
coat
dilut
antihuman
igm
kirkegaard
perri
laboratori
dilut
human
serum
sampl
ad
four
well
two
well
ad
posit
antigen
inactiv
rvfv
cultur
fluid
also
sourc
antigen
igg
sandwich
elisa
two
well
neg
antigen
mock
cultur
fluid
well
react
antirvfv
hmaf
react
dilut
hrp
conjug
antimous
igg
kirkegaard
perri
laboratori
color
develop
done
ad
abt
substrat
similar
igg
sandwich
elisa
determin
reactiv
rrvfvn
inactiv
virusbas
igm
captur
elisa
system
serum
sampl
test
use
describ
procedur
inactiv
rvfv
antigen
altern
rrvfn
ngwell
rrvfvnbase
igm
captur
elisa
follow
step
inactiv
virusbas
elisa
system
modif
serum
sampl
test
well
coat
dilut
antihuman
igm
cappel
mp
biochem
dilut
human
serum
ad
well
two
well
ad
ng
rrvfvn
protein
posit
antigen
two
well
ad
ng
rsftsvn
protein
neg
antigen
dilut
antirvfv
rabbit
hyperimmun
serum
ad
four
well
dilut
peroxidas
conjug
antirabbit
igg
american
qualex
califonia
usa
ad
color
develop
done
ad
abt
substrat
rvfv
nucleocapsid
gene
encompass
codon
amino
acid
residu
full
length
rvfvn
protein
success
express
e
coli
mostli
solubl
form
sequenc
read
frame
n
gene
confirm
sequenc
dna
recombin
plasmid
rrvfvn
protein
purifi
supernat
talon
metal
affin
column
nondenatur
condit
sdspage
coomassi
blue
stain
reveal
singl
protein
band
kda
predict
fig
ident
rrvfvn
protein
confirm
western
blot
rvfv
rabbit
hyper
immun
serum
mous
antibodi
histidinetag
fig
serum
sampl
collect
human
volunt
rvf
surveil
od
valu
inactiv
virusbas
igg
sandwich
elisa
system
compar
valu
inactiv
viru
antigen
replac
rrvfvn
antigen
fig
similar
od
valu
also
observ
human
serum
sampl
collect
rvf
outbreak
inactiv
virusbas
igm
captur
elisa
system
inactiv
viru
antigen
rrvfvnantigen
appli
fig
among
human
serum
sampl
includ
sampl
test
collect
rvf
surveil
programm
kenya
sampl
igg
posit
igg
neg
igg
sandwich
elisa
system
result
perfectli
match
inactiv
virusbas
igg
sandwich
elisa
result
sensit
specif
system
concord
inactiv
viru
base
elisa
system
tabl
among
human
serum
sampl
includ
sampl
test
collect
rvfsuspect
patient
outbreak
kenya
sampl
igm
posit
igm
neg
igm
captur
elisa
use
new
igm
captur
elisa
system
result
perfectli
match
inactiv
viru
base
igm
captur
elisa
result
system
sensit
specif
concord
inactiv
viru
base
igm
elisa
system
tabl
success
express
rrvfvn
protein
e
coli
purifi
protein
near
homogen
histag
base
affin
chromatographi
nativ
condit
fig
purifi
rrvfvn
protein
react
rvfv
rabbit
hyper
immun
serum
mous
antihistidin
antibodi
western
blot
fig
express
rrvfvn
protein
solubl
form
purif
process
done
nativ
condit
without
use
deterg
therebi
omit
tediou
process
refold
denatur
protein
express
purif
procedur
describ
studi
provid
simpl
effici
way
obtain
pure
rrvfvn
protein
larg
quantiti
fig
westernblot
analysi
purifi
rvfvn
protein
prestain
protein
marker
purifi
recombin
rvfvn
protein
separ
sdspage
transfer
pvdf
membran
membran
incub
dilut
rabbit
rvf
hyperimmun
sera
mous
antihistidin
serum
follow
horseradish
peroxidas
hrp
conjug
antirabbit
igg
antimous
igg
dilut
detect
dab
stain
reactiv
recombin
protein
rabbit
rvf
hyperimmun
sera
b
reactiv
recombin
protein
mous
antihistidin
antibodi
lane
protein
marker
precis
plu
protein
standard
biorad
lane
purifi
rvfvn
protein
fig
comparison
rrvfvn
protein
inactiv
rvfv
antigen
inactiv
viru
basedigg
sandwich
elisa
system
inactiv
virusbas
igg
sandwich
elisa
system
use
rvf
diagnosi
refer
laboratori
use
evalu
rrvfvn
protein
replac
inactiv
viru
antigen
rvfv
cultur
fluid
rrvfvn
protein
twelv
human
serum
sampl
collect
rvf
surveil
test
use
viru
cultur
fluid
x
axi
rrvfvn
protein
antigen
axi
fafetin
et
al
report
indirect
igg
indirect
igm
elisa
system
domest
sheep
goat
cattl
compar
recombin
n
protein
base
indirect
igg
elisa
igg
sandwich
elisa
use
sera
collect
small
domest
rumin
jansen
van
vuren
et
al
report
indirect
igg
indirect
igm
elisa
system
human
sheep
use
recombin
rvfv
n
protein
coat
antigen
paweska
et
al
evalu
recombin
n
protein
base
indirect
igg
elisa
human
african
buffalo
william
et
al
develop
igm
captur
elisa
domest
anim
report
rrvfvn
protein
work
well
antigen
prove
use
rrvfvn
protein
report
use
indirect
igg
igm
elisa
system
coat
reagent
assay
antigen
turn
allow
react
test
serum
supposedli
contain
primari
antibodi
follow
enzymelabel
secondari
antibodi
recombin
rvfvn
proteinbas
igg
sandwich
elisa
igm
captur
elisa
system
human
report
unlik
indirect
elisa
igg
sandwich
igm
captur
elisa
antibodi
coat
reagent
captur
assay
antigen
igm
test
sera
respect
shown
small
rumin
igg
sandwich
elisa
sensit
igg
indirect
elisa
human
diagnosi
indirect
igm
elisa
suffer
potenti
falseposit
result
exist
rheumatoid
factor
individu
falseneg
result
competit
igg
antibodi
igm
captur
elisa
recommend
sensit
specif
detect
evalu
reactiv
rrvfvn
protein
inactiv
virusbas
igg
sandwich
elisa
igm
captur
elisa
use
human
serum
sampl
elisa
system
show
among
sampl
test
igg
fig
anoth
sampl
igm
fig
result
use
rrvfvn
protein
perfectli
match
use
inactiv
viru
antigen
indic
n
protein
import
immunoreact
compon
rvfv
use
rrvfvn
protein
develop
igg
sandwich
elisa
igm
captur
elisa
human
serum
compar
inactiv
virusbas
elisa
system
appli
healthi
human
serum
sampl
collect
rvf
surveil
programm
kenya
serum
sampl
collect
rvfsuspect
patient
rvf
outbreak
show
rrvfvn
proteinbas
igg
sandwich
elisa
tabl
igm
captur
elisa
tabl
concord
inactiv
virusbas
elisa
system
sensit
specif
find
clearli
demonstr
use
rrvfvn
proteinbas
elisa
system
reliabl
clinic
diagnosi
rvfv
infect
human
compar
inactiv
viru
basedelisa
use
research
rvf
diagnosi
rrvfvn
proteinbas
elisa
use
studi
offer
sever
distinct
advantag
elimin
use
infecti
viru
antigen
product
easier
way
standard
test
variabl
factor
viru
multipl
infect
viru
strain
cell
line
cell
condit
associ
prepar
inactiv
viru
longer
present
short
period
time
within
week
clone
low
cost
requir
prepar
recombin
antigen
would
especi
use
case
largescal
epidemiolog
investig
applic
develop
countri
recombin
rvfvn
safe
afford
antigen
rvf
diagnosi
howev
current
evalu
use
small
number
sampl
thu
indepth
valid
assay
requir
could
use
replac
current
accept
assay
base
whole
antigen
newli
establish
rrvfvnbase
igg
sandwich
igm
captur
elisa
system
may
offer
safe
reliabl
tool
diagnosi
rvfv
infect
human
especi
use
largescal
epidemiolog
investig
applic
develop
countri
